Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • For the third quarter 2013, analysts estimate IPXL will generate revenues of $111.8M, a decrease of 23.19% over the prior year third quarter results.
    IPXL reported today that the total revenues were $132.6 million for the third quarter 2013, compared to $145.6 million in the prior year period.
    IPXL also reported that the third quarter 2013 adjusted net income of $16.6 million, or $0.25 per diluted share, compared to adjusted net income of $33.0 million, or $0.48 per diluted share in the prior year period.
    Adjusted earnings before interest, taxes, depreciation and amortization was $34.2 million in the third quarter 2013, compared to $57.3 million in the prior year period.
    Cash and short-term investments increased $137.7 million to $436.6 million as of September 30, 2013, compared to $298.9 million as of December 31, 2012.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
45.74+0.87(+1.94%)Mar 27 4:00 PMEDT